Empowered Patient Radio-logo

Empowered Patient Radio

Health, Home & Life

Empowered Patient Radio podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, the emergence of personalized medicine, aging in place, wearables and sensors, clinical trials and advances in clinical research, payer trends, transparency in the medical marketplace and challenges for connected health entrepreneurs. Formerly called Empowered Patient Radio, this show continues to evolve driven by the convergence of a diverse array of industries.

Empowered Patient Radio podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, the emergence of personalized medicine, aging in place, wearables and sensors, clinical trials and advances in clinical research, payer trends, transparency in the medical marketplace and challenges for connected health entrepreneurs. Formerly called Empowered Patient Radio, this show continues to evolve driven by the convergence of a diverse array of industries.

Location:

San Diego, CA

Description:

Empowered Patient Radio podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, the emergence of personalized medicine, aging in place, wearables and sensors, clinical trials and advances in clinical research, payer trends, transparency in the medical marketplace and challenges for connected health entrepreneurs. Formerly called Empowered Patient Radio, this show continues to evolve driven by the convergence of a diverse array of industries.

Twitter:

@karenjagoda

Language:

English


Episodes

Treating Essential Tremors with Bioelectronic Wearable Device with Renee Ryan Cala Health

2/24/2020
Renee Ryan, CEO, Cala Health talks about the focus of Cala on using electricity as medicine by developing wearable electronics to treat tremors in the hands of essential tremor patients. Using neuromodulation technology, they have developed a device that includes a stimulator and a signal that is sent across two nerves in the wrist to read the frequency of the tremors and allow the patient to reduce tremors on demand. @calahealth #mobilehealth #essentialtremors #neuromodulation Cala...

Duration:00:16:01

Advancing Epigenetic Therapies to Treat Liver Diseases with James Brown DVM DURECT

2/19/2020
James Brown DVM, CEO, DURECT Corporation talks about how DURECT is advancing epigenetic therapies to treat alcoholic hepatitis and non-alcoholic steatohepatitis (NASH). The company's lead asset, DUR-928 has demonstrated promising therapeutic potential treating patients with alcoholic hepatitis, a life-threatening acute liver disease caused by chronic alcohol abuse with no approved drugs for treatment. Dr. Brown also talks about his background as a doctor of veterinary medicine and his goal...

Duration:00:16:02

Raising Awareness About Huntington's and Other Rare Diseases with Maria Picone TREND Community and Antonio Maltese

2/18/2020
Maria Picone, co-founder TREND.Community and Antonio Maltese, student with Huntington's Disease talk about the challenges of finding valid information about rare diseases, the value of community support in discovering novel approaches to treatments, providing evidence to pharmaceutical companies about little understood symptoms, and advocating for awareness about rare diseases particularly during Rare Disease week and Rare Disease Day February 29. #rarediseases...

Duration:00:16:00

Developing Novel Therapies for Central Nervous System Diseases with Brad Margus Cerevance

2/17/2020
Brad Margus, CEO, Cerevance talks about discovering and developing novel therapies for central nervous system diseases using the Cerevance powerful NETSseq target discovery platform and their large collection of human brain tissue samples. Brad explains why the brain is such a challenging organ to study and their efforts to understand brain cell loss in such diseases as Parkinson's and Alzheimer's. #brain #CNSdisorders #Parkinsons #Alzheimers #NETSseq Cevevance.com Download the transcript...

Duration:00:16:28

Using Genetic Testing to Advance Healthcare for Women with Brad Robinson Predictive Technology Group

2/12/2020
Brad Robinson, CEO, Predictive Technology Group talks about the company's work focusing on women's health and why they decided to focus on this neglected field that has significant unmet medical needs. Brad discusses the importance of genetics in informing a woman's course of care. Brad also talks about the company's subsidiaries Predictive Analytics, Predictive Laboratories, and Predictive Biotech and how the synergy between these entities is instrumental in helping women and their...

Duration:00:15:51

Improving Efficacy of Colorectal Cancer Treatments with Ulf Jungnelius MD Isofol Medical

2/11/2020
Ulf Jungnelius MD, CEO, Isofol Medical discusses the increasing incidence of colorectal cancer as a global issue and the current challenges in treating this devastating disease. Dr. Jungnelius also talks about the company's drug candidate, arfolitixorin, currently being studied in a global Phase 3 clinical trial with the aim to improve the efficacy of standard of care chemotherapy for advanced colorectal cancer. #colorectalcancer #CRC #ColonCancer #MetastaticColorectalCancer #chemotherapy...

Duration:00:17:12

Understanding B-Cells to Stimulate Immune Response to Cancer with Purnanand Sarma immunome

2/10/2020
Purnanand Sarma, CEO, Immunome discusses why a lot of cancers still remain untreatable today and the company's new approach to fight cancer by tapping into the body's natural immune response against disease. Sarma further talks about why Immunome chose to look at cancer through the lens of the B-cell in order to identify novel antibody-target pairs. #BCell #Antibody #ImmuneResponse #cancer Immunome.com Download the transcript here

Duration:00:17:13

Allogeneic CAR-T Immunotherapies Showing Promise for Solid Tumors with Filippo Petti Celyad

2/5/2020
Filippo Petti, CEO, Celyad discusses how the company is broadening precision medicine by developing CAR-T immunotherapies to express a natural killer receptor that can recognize and target multiple ligands expressed in up to 80% of all cancers. Filippo talks about the value to cancer patients of both personalized (autologous) and off the shelf (allogeneic) CAR-T therapies and CYAD-101, Celyad's allogeneic CAR-T therapy, that demonstrated for the first time ever, clinical effectiveness in...

Duration:00:16:14

Developing Therapeutics for Rare Pediatric Diseases with Nevan Elam Rezolute

2/3/2020
Nevan Elam, J.D. CEO and co-founder Rezolute, Inc. talks about their work developing therapeutics for congenital hyperinsulinism, a rare pediatric disease and for diabetic macular edema, a vision-related complication of diabetes. With a background of working with technology businesses, Nevan reflects on lessons learned and differences in drivers of innovation in the computer and biotech worlds. @rezolutebio #RareDisease #PediatricDisease #DME #DiabeticMacularEdema #Diabetes...

Duration:00:15:54

Discovering New Drug Targets for Treating Solid Tumors with Dr. Anat Cohen-Dayag Compugen

1/29/2020
Anat Cohen-Dayag PhD chief executive officer, Compugen discusses the current immune-oncology treatment landscape, with only 20-30% of patients responding to currently available treatments, and the missing link that she believes her company may have found to improve the success rate. Anat talks about how Compugen's computational discovery platform works to discover new drug targets for treating solid tumors and how lead candidate COM701 has shown encouraging early stage results to...

Duration:00:17:11

Finding Lung Cancer Earlier with Ronnie Andrews Oncocyte

1/27/2020
Ronnie Andrews, CEO, Oncocyte discusses the company's mission to answer critical questions along the cancer care continuum through the use of their molecular tests for diagnosis and treatment of early stage lung cancer. Ronnie also talks about the changes in cancer care over the past 20 years and the potential these tests have to positively impact patients in the future. @oncocyteLBX #moleculardiagnostics #lungcancer #liquidbiopsy #earlydetection Oncocyte.com Download the transcript here

Duration:00:16:26

On Demand Patient Care with Dr. Brad Younggren 98point6

1/21/2020
Brad Younggren MD, Chief Medical Officer, 98point6 talks about what happens when a company fundamentally changes the way patients interact with doctors by providing 24/7 on-line access to medical professionals aided by the camera and attachments on mobile devices to further inform the diagnosis and treatment plan. With enthusiastic support from traditional primary care doctors, this new model of on-demand care is showing effectiveness for addressing emergency as well as chronic...

Duration:00:16:59

Targeting Specific Proteins to Treat Triple Negative Breast Cancer with Usama Malik Immunomedics

1/12/2020
Usama Malik, Chief Financial Officer and Chief Business Officer, Immunomedics discusses the challenges of developing effective medicines for people with triple negative breast cancer as well as Immunomedics' development of antibody-drug conjugates, directed therapies which have potential to provide new options for those with hard to treat cancers. @immunomedicsinc #breastcancer #TNBC #HER2 #TripleNegative #bladdercancer #urothelial Immunomedics.com Download the transcript here

Duration:00:16:19

T Cell Redirection Drives Natural Immune Response Against Solid Tumors with Asher Nathan NeoTX

1/8/2020
Dr. Asher Nathan, CEO of NeoTX talks about the company's work developing immunotherapies for a wide range of solid tumors using their proprietary Selective T Cell Redirection (STR) platform. This technology enables therapies that bind a genetically engineered super antigen to the tumor surface which trigger a native, controlled immune response that can kill the cancer with potentially fewer side effects than currently available therapies. Asher discusses the company's lead STR molecule, NAP,...

Duration:00:15:08

Monoclonal Antibody Treatments Shown Safe for HIV and Other Indications with Dr. Nader Pourhassan CytoDyn

1/6/2020
Dr. Nader Pourhassan, is Director, President, and CEO, CytoDyn, a late-stage biotechnology company developing leronlimab (PRO 140), a targeted therapy with the potential to treat multiple diseases. Nader highlights CytoDyn's ongoing clinical trial evaluating leronlimab for metastatic triple negative breast cancer (mTNBC) and the company's plans to submit a Biologics License Agreement (BLA) to the U.S. Food and Drug Administration (FDA) for leronlimab in combination with highly active...

Duration:00:15:42

Raising Awareness About Congenital Rubella Syndrome with Janet Lee CRS Patient Advocate

12/19/2019
Janet Lee is a patient advocate for those suffering from Congenital Rubella Syndrome (CRS) and is on a mission to educate healthcare professionals, patients, and caregivers about the delayed manifestations of this disease. This is also a story about a mother who was not vaccinated for Rubella and who gave birth to Janet who was born with extreme hearing loss and suffers from other complications from CRS. Thanks to her mother's intensive training and love, Janet learned to read lips was able...

Duration:00:13:37

Advantages of On Demand In-Home Health Testing with Dr. Rob Mordkin LetsGetChecked

12/16/2019
Dr. Rob Mordkin is Chief Medical Officer for LetsGetChecked.com and Chief of Urology at the Virginia Hospital Center. We talk about his strong belief in giving individuals access to in-home health testing to allow them to check on warning signs, confirm findings of other lab tests, and provide on-going monitoring of chronic conditions. With or without a primary care doctor, patients can order tests, have results reviewed by a physician, discuss findings with a nurse, and if necessary,...

Duration:00:17:15

Overcoming Clinical Trial Obstacles with Mike Wenger TrialScope

12/11/2019
Mike Wenger, Vice President of Patient Engagement, TrialScope is thinking about ways to improve the clinical trials process by focusing more on the patients that are being recruited, tracked and retained. We talk about the need to overcome challenges of enrollment, helping patients find the right clinical trial, and reducing the costs related to the time-consuming process of conducting clinical trials. @TrialScope TrialScope.com Read the transcript here

Duration:00:16:18

New Platform for Next Generation Immunotherapy with Anish Suri Cue Biopharma

12/5/2019
Anish Suri, President and Chief Scientific Officer, Cue Biopharma discusses their proprietary Immuno-STAT platform. Cue Biopharma is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. The company's proprietary platform Immuno-STAT (Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo...

Duration:00:16:53

Targets of Opportunity for Medicinal Cannabis Research with Dr. Igor Grant CMCR UCSD

11/19/2019
Dr. Igor Grant, Director, Center for Medicinal Cannabis Research at the University of California San Diego talks about the need for basic science studies on new indications and promises of cannabinoids, potential medical effects of both THC and CBD, the uptick in funding for clinical studies, relative safety of cannabis compared to other drugs, and which diseases and chronic conditions are currently being effectively treated with some form of cannabis. CMCR.UCSD.edu Download the transcript...

Duration:00:17:52